Additionally, inhibiting ATXN2 through siRNA increases the efficiency of nanoparticle delivery to tumor cells, making ATXN2 a potential reference for nanoparticle delivery prediction in cancer cells [127]. The gene discussed is ATXN2; the disease is neoplasm.